加自选 万辰集团同时公告，公司董事会决定聘请富睿玛泽为本次发行并上市的审计机构。 万辰集团，作为一家农业产业化国家重点龙头企业，年产食用菌14万吨，致力于将优质的食用菌产品和 服务带给全球消费者。万辰集团拥有业内齐全的品项系列，产品多渠道覆盖全国市场，并远销东南亚及 欧美。万辰集团的营销网络已遍布全国主要城市的农批市场，并与华润苏果、大润发、沃尔玛、新华都 等大型连锁超市及美团、兴盛优选、朴朴、多多买菜等电商平台展开深入合作，产品进入千家万户。在 东南亚市场，万辰产品在越南、泰国等具有较高的品牌知名度和认可度，在欧美，万辰集团的市场正在 不断扩大。 万辰集团(SZ:300972) 深級通 可融资 可卖空 ¥150.11 -2.29-1.50% | 1.70 万球友关注 | | --- | | 体市 08-22 15:34:30 北京时间 | | 最高:153.81 | 今开:152.40 | 涨停:182.88 | 成交量:25524手 | | --- | --- | --- | --- | | 最低:148.00 | 昨收:152.40 | 跌停:121.92 | 成交额:3.85亿 | | 换手:1.56 ...

Group 1 - The company reported a total operating revenue of 908 million yuan for the first half of 2025 [1] - The net profit attributable to shareholders reached 69.02 million yuan, an increase of 39.54 million yuan compared to the same period last year, representing a year-on-year growth of 134.13% [1] - The net cash inflow from operating activities was 150 million yuan [1] Group 2 - The latest debt-to-asset ratio of the company is 49.72% [3] - The gross profit margin improved to 19.41%, an increase of 1.69 percentage points compared to the same period last year [3] - The return on equity (ROE) is 2.12%, up by 1.24 percentage points year-on-year [3] Group 3 - The diluted earnings per share (EPS) is 0.18 yuan, an increase of 0.11 yuan compared to the same period last year, reflecting a year-on-year rise of 145.33% [3] - The total asset turnover ratio is 0.14 times [3] - The inventory turnover ratio is 0.57 times [3] Group 4 - The number of shareholders is 33,400, with the top ten shareholders holding a total of 176 million shares, accounting for 44.75% of the total share capital [3] - The top shareholder is Tao Shi, holding 28.0 million shares [3] - Other notable shareholders include Tian De with 7.92 million shares and the first employee stock ownership plan with 2.29 million shares [3]

Core Insights - The company reported a revenue of 908 million yuan for the first half of 2025, a year-on-year decrease of 0.7% [1] - The net profit attributable to shareholders reached 69.02 million yuan, showing a significant year-on-year increase of 134.1% [1] - In Q2, the company achieved a revenue of 435 million yuan, reflecting a year-on-year growth of 1.7% [1] - The net profit for Q2 turned positive at 20.82 million yuan, compared to a loss of 5.27 million yuan in the same period last year [1] Business Operations - The company's main business operations have not undergone significant changes [1] - The wholly-owned subsidiary Changhong Agriculture has been under suspension since May 2024 for technical upgrades, focusing on the research and cultivation of rare medicinal fungi, particularly the industrialized bionic cultivation of Cordyceps sinensis [1] - The technical upgrades for the Cordyceps project have been partially completed, and it has entered the trial production phase [1] - During the reporting period, the revenue from bionic Cordyceps products was 4.85 million yuan, accounting for 0.53% of the company's total revenue [1]

Core Viewpoint - The recent financial report of Zhongxing Junye (002772) shows a mixed performance with a slight decline in total revenue but a significant increase in net profit, indicating improved profitability despite challenges in revenue growth [1]. Financial Performance Summary - Total revenue for the first half of 2025 was 908 million yuan, a decrease of 0.75% year-on-year [1]. - Net profit attributable to shareholders reached 69.02 million yuan, an increase of 134.13% year-on-year [1]. - In Q2 2025, total revenue was 435 million yuan, up 1.69% year-on-year, while net profit was 20.82 million yuan, up 495.21% year-on-year [1]. - Gross margin improved to 19.41%, a year-on-year increase of 9.56%, and net margin rose to 7.5%, up 139.76% year-on-year [1]. - Total expenses (selling, administrative, and financial) amounted to 118 million yuan, accounting for 12.97% of revenue, a decrease of 10.73% year-on-year [1]. Key Financial Ratios - Earnings per share (EPS) increased to 0.18 yuan, a rise of 145.33% year-on-year [1]. - Operating cash flow per share was 0.38 yuan, down 16.76% year-on-year [1]. - The company's return on invested capital (ROIC) was 3.02% last year, indicating generally weak capital returns [1]. - The debt ratio (interest-bearing liabilities) reached 41.53%, highlighting the company's debt situation [2]. Fund Holdings - The largest fund holding Zhongxing Junye is the Manulife Consumer Dividend Index A, with a scale of 576 million yuan and a recent net value increase of 1.14% [3]. - Other funds such as the Caitong Huazhen Quantitative Stock Mixed A have also increased their holdings in the company [2].

此外，众兴菌业全资子公司眉山昌宏农业生物科技有限公司自2024年5月份起实施技改，探索珍稀食药 用菌的研发与培植，主要实施冬虫夏草工厂化仿生培育项目。项目部分技改完成并陆续进入试生产，报 告期内，公司实现冬虫夏草（仿生）产品营业收入484.51万元。 （编辑 张伟） 众兴菌业是从事食（药）用菌研发、工厂化培植与销售的现代农业企业。目前已在甘肃、陕西、山东、 江苏、河南、四川、安徽、湖北等地建立了生产基地。 今年以来，众兴菌业根据"立足西北、面向全国、走向世界"的生产基地布局战略以及"以金针菇和双孢 菇为主，多品种协同发展"的种植品种发展战略，在以金针菇和双孢菇为主的基础上，积极推进冬虫夏 草工厂化生态繁育项目，促进公司业务多元化，增加新的盈利增长点，提升公司抗风险能力。 具体来看，今年上半年，众兴菌业全资子公司陕西众兴高科生物科技有限公司对原金针菇生产线停产进 行改造、投资实施"冬虫夏草工厂化仿生培育更新改造项目"，项目正在建设中；公司与金堂县人民政府 等签订项目投资协议书、项目投资补充协议书等，投资设立四川众兴菌业科技有限公司（以下简称"四 川众兴"）并实施"食药用菌产业园西南总部基地项目"，重点开展冬虫夏 ...

Core Insights - The company reported a total revenue of 908 million yuan for the first half of 2025, a decrease of 6.83 million yuan compared to the same period last year, representing a year-on-year decline of 0.75% [1] - The net profit attributable to shareholders was 69.02 million yuan, while the net cash inflow from operating activities was 150 million yuan, down 30.31 million yuan from the same period last year, reflecting a year-on-year decrease of 16.76% [1] Financial Ratios - The latest debt-to-asset ratio stands at 49.72%, which is an increase of 2.16 percentage points from the previous quarter and an increase of 3.93 percentage points compared to the same period last year [3] - The latest gross profit margin is 19.41%, down 3.71 percentage points from the previous quarter [3] - The return on equity (ROE) is reported at 2.12% [3] Earnings and Turnover - The diluted earnings per share (EPS) is 0.18 yuan [4] - The total asset turnover ratio is 0.14 times, a decrease of 0.01 times compared to the same period last year, reflecting a year-on-year decline of 4.08% [4] - The inventory turnover ratio is 0.57 times, down 0.03 times from the same period last year, indicating a year-on-year decline of 4.41% [4] Shareholder Structure - The number of shareholders is 33,400, with the top ten shareholders holding a total of 176 million shares, accounting for 44.75% of the total share capital [4] - The top shareholders include: - Tush (28.0 million shares) - Tian De (7.92 million shares) - Tianshui Zhongxing Junye Technology Co., Ltd. - First Employee Stock Ownership Plan (2.29 million shares) [4]

Core Viewpoint - The document outlines the annual report work system for independent directors of Tianshui Zhongxing Mushroom Industry Technology Co., Ltd, emphasizing the importance of governance, internal control, and the responsibilities of independent directors in the annual report preparation and disclosure process [2][5]. Group 1: Governance and Responsibilities - The company aims to enhance its governance mechanism and establish a sound internal control system to ensure independent directors effectively fulfill their roles in annual report information disclosure [2]. - Independent directors are required to diligently perform their duties, ensuring that all necessary disclosures in the annual report are truthful, complete, and accurate [3][4]. - The management must report to independent directors on the company's operational status, investment, financing activities, and significant financial results throughout the year [3][4]. Group 2: Confidentiality and Compliance - Independent directors have a confidentiality obligation during the annual report preparation and must prevent insider information leaks and insider trading violations [3]. - There are specific trading restrictions for independent directors, prohibiting them from buying or selling company stock within certain timeframes before the annual report disclosure [3]. Group 3: Oversight and Communication - Independent directors are responsible for verifying the qualifications of the accounting firm and the auditors involved in the annual report audit [4]. - They must communicate with the auditors regarding various aspects of the company's performance, including revenue, profit changes, and significant financial data variations [4]. Group 4: Review and Approval Process - Before the board meeting to review the annual report, independent directors must ensure that all necessary procedures and documentation are in place for a reasonable and accurate judgment [4]. - Independent directors are required to sign written confirmation opinions on the annual report, and if they have objections, they must state their reasons and disclose them [4][5]. Group 5: External Consultation - If independent directors have dissenting opinions on specific matters in the annual report, they can independently hire external audit and consulting firms, with the associated costs borne by the company [5]. Group 6: Implementation and Amendments - The document stipulates that any matters not covered will be executed according to national laws and regulations, and the board of directors is responsible for interpreting and amending the system [5].

天水众兴菌业科技股份有限公司 互动易平台信息发布及回复内部审核制度 天水众兴菌业科技股份有限公司 甘肃·天水 二○二五年八月 天水众兴菌业科技股份有限公司 互动易平台信息发布及回复内部审核制度 天水众兴菌业科技股份有限公司 第一章 总 则 第一条 为充分利用深圳证券交易所（以下简称"深交所 "）搭建的投资者 关系互动平台（以下简称"互动易平台"），规范天水众兴菌业科技股份有限公 司（以下简称"公司"）通过互动易平台与投资者交流，建立公司与投资者良好 沟通机制，持续提升公司治理水平，提高公司质量，根据《上市公司信息披露管 理办法》、《深圳证券交易所股票上市规则》及《深圳证券交易所上市公司自律 监管指引第 1 号——主板上市公司规范运作》等相关法律、法规和规范性文件及 《公司章程》的相关规定，结合公司实际情况，特制定本制度。 第二章 舆情管理的组织体系及其工作职责 第二条 公司在互动易平台发布信息及回复投资者提问，应当注重诚信，严 格遵守有关规定，尊重并平等对待所有投资者，主动加强与投资者的沟通，增 进投资者对公司的了解和认同，营造健康良好的市场生态。 公司信息披露以指定信息披露媒体披露的内容为准，不得通过互动易 ...

天水众兴菌业科技股份有限公司 股东会议事规则 天水众兴菌业科技股份有限公司 甘肃·天水 第三条 公司应当严格按照法律、行政法规、本规则及《公司章程》的相关 规定召开股东会，保证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当 勤勉尽责，确保股东会正常召开和依法行使职权。 第四条 股东会应当在《公司法》和《公司章程》规定的范围内行使职权。 第五条 股东会分为年度股东会和临时股东会。年度股东会每年召开一次， 应当于上一会计年度结束后的六个月内举行。临时股东会不定期召开，出现《公 司法》第一百一十三条规定的应当召开临时股东会的情形时，临时股东会应当在 二个月内召开。 二○二五年八月 天水众兴菌业科技股份有限公司 股东会议事规则 天水众兴菌业科技股份有限公司 第一章 总 则 第一条 为规范天水众兴菌业科技股份有限公司（以下称"公司"或"本公 司"）行为，保证股东会依法行使职权，根据《中华人民共和国公司法》（以下 简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司股东会规则》、《深圳证券交易所上市公司自律监管指引第 1 号—主 板上市公司规范 ...

Core Points - The document outlines the management system for the shares held by directors and senior management of Tianshui Zhongxing Mushroom Industry Technology Co., Ltd, emphasizing compliance with relevant laws and regulations [2][3][16] Group 1: General Provisions - The management system is established to strengthen the oversight of shares held by directors and senior management, in accordance with the Company Law and Securities Law of the People's Republic of China [2] - The system applies to directors, senior management, and other specified individuals or organizations holding shares in the company [2] - Shares held by directors and senior management include those registered in their names and those held in others' accounts [2] Group 2: Information Reporting - Directors and senior management must report their personal and immediate family members' information to the Shenzhen Stock Exchange within specified timeframes [7][8] - The reported information is considered an application for managing their shares according to relevant regulations [4] Group 3: Share Lock-up - Shares acquired by directors and senior management through various means are subject to a 75% automatic lock-up for newly acquired unrestricted shares within a year of the company's listing [6] - Conditions for transferring shares held by directors and senior management include performance assessments and lock-up periods [10] Group 4: Share Trading Restrictions - Directors and senior management are prohibited from transferring shares within six months of leaving their positions and are limited to selling no more than 25% of their holdings annually [7][16] - Specific periods are defined during which directors and senior management cannot buy or sell shares, particularly around financial report announcements [8][9] Group 5: Information Disclosure - Changes in shareholdings by directors and senior management must be disclosed within two trading days [12] - Any planned share reductions must be reported to the Shenzhen Stock Exchange 15 trading days in advance [21] Group 6: Compliance and Penalties - Violations of the share trading regulations result in the company reclaiming any profits made from such transactions [16] - The board of directors is responsible for interpreting and revising the management system [29]